Gene and Cell Therapy – Multimedia

In medicine, gene therapy is the process where nucleic acids are delivered to a patient’s cells as a therapeutic drug to treat an array of genetic diseases. All gene therapies utilize either viral or non-viral vectors to deliver the DNA or RNA into the host cell.

An AAV is a non-enveloped virus with a lack of pathogenicity, low immunogenicity, broad tropism and persistent transgene expression in both proliferating and quiescent cells. This makes AAVs an attractive choice for creating viral vectors for gene therapy for a variety of diseases.

Cell and gene therapies are continuing to gain popularity, with 15 now FDA approved and hundreds more in development. While these treatments are promising, managing safety and effectiveness in patients is complex.

One of the more promising types of cancer immunotherapy involves engineering immune cells to recognize and attack cancer.

The successful use of immunotherapies to help combat cancer has expanded rapidly in the last few years, with many therapies now approved for clinical use.

Download this compendium to discover solutions for bioanalysis of antibody drugs, peptide mapping and detection of protein aggregates.

This e-book is a compelling introduction to HYPER technology and the impact it has had as an industry standard on a variety of adherent cell expansion applications, including viral vector manufacturing and stem cell expansion.

As we have gained a greater understanding of cancer biology, therapeutic interventions have evolved from a one-size-fits-all approach to more targeted approaches, which afford patients not only longer lives but increased quality of life.

In this cell and gene therapy insights expert roundtable, a panel of four experts will answer some central questions surrounding the development of novel biotherapeutics.

Download this app note to discover immunoassay platforms that are consistent for your cell therapy and immunology development needs.